Diet plus home exercise for people with peripheral artery disease and leg pain
Tests the DASH diet added to home exercise in peripheral artery disease.
Key facts
- Who runs it
- University of Oklahoma
- Where
- Oklahoma City, United StatesSee the site
- Trial code
- Registry title
- The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 16 Sept 2024
- Expected to end
- 31 May 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- DASH Diet plus Home-Based Exercise
- Home-Based Exercise
- Record updated
- 17 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with peripheral artery disease (narrowed leg arteries) who get leg pain when walking (claudication). It tests the DASH diet plus home walking against home walking alone.
- Age
- 40 Years and older
- Sex
- All sexes
- Disease stage
- Peripheral artery disease with a history of claudication. People with leg pain at rest or tissue loss (Fontaine stage III or IV; Rutherford Grade II or III) cannot join.
- Earlier treatment
- A past procedure to reopen leg arteries (peripheral revascularization) can count as proof of PAD. People who had such a procedure within one month cannot join. People who started cilostazol or pentoxifylline within three months cannot join.
- Biomarker or test result
- PAD shown by one of: ABI (ankle-brachial index, a blood pressure ratio) at rest < 0.90; or > 20% drop in ABI after a heel-rise exercise test when resting ABI is normal (> 0.90); or past peripheral revascularization. ABI > 1.40 is not allowed.
Main reasons for not taking part
- Leg pain at rest or tissue loss due to PAD
- Active cancer
- End stage kidney disease (stage 5 chronic kidney disease)
- Health problems that make exercise unsafe according to the American College of Sports Medicine
- Memory or thinking problems (mini-mental state examination score < 24)
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- History of claudication,
- Presence of PAD, defined by meeting at least one of the following criteria (ABI at rest < 0.90, or > 20% decrease in ABI following a heel-rise exercise test in patients with a normal ABI at rest (> 0.90), or history of peripheral revascularization
Who cannot take part
- use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation,
- peripheral revascularization within one month prior to investigation,
- absence of PAD, defined by meeting all of the following 3 criteria (ABI at rest > 0.90), < 20% decrease in ABI following a heel-rise exercise test, and no history of peripheral revascularization,
- active cancer,
- end stage renal disease defined as stage 5 chronic kidney disease,
- medical conditions that are contraindicative for exercise according to the American College of Sports Medicine,
- failure to complete the baseline tests within three weeks
- non-compressible vessels (ABI > 1.40),
- rest pain due to PAD (Fontaine stage III; Rutherford Grade II),
- tissue loss due to PAD (Fontaine stage IV; Rutherford Grade III),
- cognitive dysfunction (mini-mental state examination score < 24), and
Where in United States
- O'Donoghue Research Building, University of Oklahoma Health Sciences CenterOklahoma City, United StatesContact: Andrew W Gardner, PhDTaking people
About the trial
What the trial wants to find out
This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.
The 2 groups in the trial
- DASH Diet plus Home-Based ExerciseTreatment being tested
The DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.
- Home-Based ExerciseExisting treatment, for comparison
The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
- Plain-language title
- Diet plus home exercise for people with peripheral artery disease and leg painGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 April 2026